The surveillance plan for bladder cancer typically involves regular follow-up appointments and tests to monitor for any recurrence or progression of the disease. The specific plan may vary based on the individual patient's situation, including the stage and grade of the bladder cancer, the type of treatment received, and the patient's overall health. Here is a general guideline for a recurrence surveillance plan for bladder cancer:

1. **Initial Follow-up after Treatment:**
- Typically, the first follow-up appointment occurs within a few weeks to a month after completing treatment.
- The focus is on assessing the patient's recovery from treatment and managing any immediate side effects.

2. **Early Surveillance:**
- The first few years after treatment often require more frequent monitoring.
- Follow-up appointments may be scheduled every 3 to 6 months initially.

3. **Regular Follow-up Visits:**
- Regular follow-up visits may include a physical examination, blood tests, and imaging studies.
- The frequency of visits may gradually decrease if there are no signs of recurrence.

4. **Cystoscopy:**
- Cystoscopy is a key component of surveillance for bladder cancer.
- Initially, cystoscopies may be done more frequently, perhaps every 3 to 6 months, and then less often as time progresses.

5. **Imaging Studies:**
- Periodic imaging studies, such as CT scans or MRIs, may be conducted to check for any signs of recurrence or metastasis.

6. **Urine Tests:**
- Regular urine tests may be performed to check for the presence of cancer cells.

7. **Urodynamic Studies:**
- In some cases, urodynamic studies may be conducted to assess bladder function.

8. **Risk Factor Assessment:**
- The healthcare team will assess and manage any ongoing risk factors, such as smoking, which is a significant risk factor for bladder cancer.

9. **Patient Education:**
- Provide ongoing education to the patient about signs and symptoms of recurrence, and encourage them to report any unusual symptoms promptly.

10. **Psychosocial Support:**
- Offer psychosocial support, as the psychological impact of a cancer diagnosis and treatment can be significant.

It's important to note that this is a general guideline, and the specific surveillance plan may vary based on individual circumstances. The healthcare team, including urologists and oncologists, will tailor the plan to meet the specific needs of each patient. Regular communication with the healthcare team is crucial for the effective management of bladder cancer and the early detection of any recurrence.